Page last updated: 2024-10-25

clebopride and Parkinsonian Disorders

clebopride has been researched along with Parkinsonian Disorders in 1 studies

clebopride: antidopaminergic; RN given refers to parent cpd; structure

Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berriozabal Diaz, L1
Zubiaurre Lizarralde, L1
Castiella Eguzkiza, A1
Zapata Morcillo, E1

Other Studies

1 other study available for clebopride and Parkinsonian Disorders

ArticleYear
[Parkinsonism due to clebopride].
    Revista espanola de enfermedades digestivas, 2011, Volume: 103, Issue:3

    Topics: Aged; Antidepressive Agents; Antiemetics; Benzamides; Citalopram; Depression; Dyspepsia; Female; Hum

2011